Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Interleukin-10 in dermatology].

K Asadullah1, W D Döcke, R Sabat

  • 1Klinik für Dermatologie, Charité, Humboldt-Universität zu Berlin.

Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|March 9, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

EBV reactivation and immunoparalysis indicate a harmful immune endotype in sepsis.

Critical care (London, England)·2026
Same author

Effectiveness, safety and quality-of-life effects of guselkumab and ustekinumab in patients with psoriasis: Week 104 results from the non-interventional, prospective, German multicentre PERSIST study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023
Same author

Early disease intervention with guselkumab in psoriasis leads to a higher rate of stable complete skin clearance ('clinical super response'): Week 28 results from the ongoing phase IIIb randomized, double-blind, parallel-group, GUIDE study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023
Same author

A comprehensive, tri-national, cross-sectional analysis of characteristics and impact of pruritus in psoriasis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

Real-world evidence from the non-interventional, prospective, German multicentre PERSIST study of patients with psoriasis after 1 year of treatment with guselkumab.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

Urban-rural disparities in old-age mortality vary systematically with age: evidence from Germany and England & Wales.

Public health·2022

Interleukin-10 (IL-10), an immunosuppressive cytokine, is implicated in skin diseases. Its overexpression is seen in inflammatory dermatoses and skin tumors, while deficiency is noted in psoriasis.

Area of Science:

  • Immunology
  • Dermatology
  • Molecular Biology

Context:

  • Cytokines are key in disease pathogenesis and emerging therapeutics.
  • Interleukin-10 (IL-10) exhibits critical anti-inflammatory and immunosuppressive functions.
  • IL-10 plays a vital role in maintaining immune homeostasis.

Purpose:

  • To elucidate the role of IL-10 in inflammatory dermatoses and skin tumors.
  • To investigate the implications of IL-10 dysregulation in skin pathophysiology.
  • To highlight the significance of IL-10 in conditions like psoriasis.

Summary:

  • Overexpression of IL-10 is observed in inflammatory skin conditions and certain skin cancers.
  • This overexpression suggests a role in down-regulating hyper-inflammatory responses and potentially suppressing anti-tumor immunity.

Related Experiment Videos

  • Conversely, a relative deficiency of IL-10 has been identified in psoriasis.

    • Impact:

    • Understanding IL-10's role aids in comprehending inflammatory skin diseases and tumor progression.
    • Therapeutic targeting of IL-10 shows promise for dermatologic disorders, particularly psoriasis.
    • IL-10 modulation represents a potential strategy for managing inflammatory and neoplastic skin conditions.